Curing Psoriasis.

Advanced therapies Biologics Cure Lifestyle modification Personalized medicine Psoriasis

Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
22 Oct 2024
Historique:
received: 25 07 2024
revised: 05 09 2024
accepted: 06 09 2024
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 22 10 2024
Statut: aheadofprint

Résumé

As medicine advances, cures are being found for diseases that were previously considered incurable, as is the case for some types of cancer. Traditionally, the term cure is reserved for resolution of disease, both at a clinical and a molecular level, which continues after cessation of treatment. Biologic therapies have revolutionized the definition of remission in severe psoriasis, with some patients achieving long-lasting disease suppression, but the disease nearly always relapses on withdrawal of the drug. Our improved understanding of the pathomechanisms of psoriasis, coupled with anecdotal reports of long-term clearance of the disease after cell-based therapies, leads us to the hypothesis that psoriasis is curable. We propose that cure of psoriasis can be achieved by restoring immune homeostasis through a combinatorial, personalized medicine approach encompassing early intervention to include biologics, advanced therapeutics, and lifestyle modification.

Identifiants

pubmed: 39436345
pii: S0022-202X(24)02161-4
doi: 10.1016/j.jid.2024.09.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Su M Lwin (SM)

St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, United Kingdom.

Shir Azrielant (S)

St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, United Kingdom; Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Juan He (J)

St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, United Kingdom; School of Medicine, Nankai University, Tianjin, China.

Christopher E M Griffiths (CEM)

St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London, United Kingdom; Centre for Dermatology Research, The University of Manchester, Manchester, United Kingdom; Department of Dermatology, King's College Hospital NHS Foundation Trust, King's College London, London, United Kingdom. Electronic address: chris.griffiths@kcl.ac.uk.

Classifications MeSH